BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 21286736)

  • 1. Photosensitizers and light sources for photodynamic therapy of the Bowen's disease.
    Calin MA; Diaconeasa A; Savastru D; Tautan M
    Arch Dermatol Res; 2011 Apr; 303(3):145-51. PubMed ID: 21286736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interventions for cutaneous Bowen's disease.
    Bath-Hextall FJ; Matin RN; Wilkinson D; Leonardi-Bee J
    Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD007281. PubMed ID: 23794286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photodynamic therapy with epidermal ablation using fractional carbon-dioxide laser in the treatment of Bowen's disease: A case series.
    Sung JM; Kim YC
    Photodiagnosis Photodyn Ther; 2017 Sep; 19():84-85. PubMed ID: 28457851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subungual Bowen's disease treated by topical aminolevulinic acid-photodynamic therapy.
    Usmani N; Stables GI; Telfer NR; Stringer MR
    J Am Acad Dermatol; 2005 Nov; 53(5 Suppl 1):S273-6. PubMed ID: 16227107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of sequential therapy in digital Bowen's disease with methyl aminolevulinate photodynamic therapy and topical diclofenac 3% in hyaluronan 2.5% gel.
    Gracia-Cazaña T; López MT; Oncins R; Gilaberte Y
    Dermatol Ther; 2015; 28(6):341-3. PubMed ID: 26291609
    [No Abstract]   [Full Text] [Related]  

  • 6. Methyl aminolevulinate: actinic keratoses and Bowen's disease.
    Morton CA
    Dermatol Clin; 2007 Jan; 25(1):81-7. PubMed ID: 17126745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Topical photodynamic therapy in basal and squamous cell carcinoma and penile Bowen's disease with 20% aminolevulinic acid, and exposure to red light and infrared light].
    Harth Y; Hirshovitz B
    Harefuah; 1998 Apr; 134(8):602-5, 672, 671. PubMed ID: 10911421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of the use of the pulsed dye laser in the treatment of Bowen's disease using 5-aminolaevulinic acid phototherapy.
    Britton JE; Goulden V; Stables G; Stringer M; Sheehan-Dare R
    Br J Dermatol; 2005 Oct; 153(4):780-4. PubMed ID: 16181460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of Bowen's disease successfully treated by photodynamic therapy.
    Kosaka S; Kawana S
    J Nippon Med Sch; 2010 Jun; 77(3):136-7. PubMed ID: 20610896
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term recurrence of nonmelanoma skin cancer after topical methylaminolevulinate photodynamic therapy in a dermato-oncology department.
    Cabete J; Rafael M; Cravo M; Moura C; Sachse F; Pecegueiro M
    An Bras Dermatol; 2015; 90(6):846-50. PubMed ID: 26734866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photodynamic therapy for subungual Bowen's disease.
    Tan B; Sinclair R; Foley P
    Australas J Dermatol; 2004 Aug; 45(3):172-4. PubMed ID: 15250896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methyl aminolaevulinate photodynamic therapy for Bowen's disease: a practical option?
    Morton CA
    Australas J Dermatol; 2005 Feb; 46 Suppl 3():S21-2; discussion S23-5. PubMed ID: 15859305
    [No Abstract]   [Full Text] [Related]  

  • 13. Periungual Bowen's disease successfully treated with photodynamic therapy.
    Zink BS; Valente L; Ortiz B; Caldas A; Jeunon T; Marques-da-Costa J
    Photodiagnosis Photodyn Ther; 2013 Dec; 10(4):535-7. PubMed ID: 24284107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photodynamic therapy in the treatment of extensive Bowen's disease.
    López N; Meyer-Gonzalez T; Herrera-Acosta E; Bosch R; Castillo R; Herrera E
    J Dermatolog Treat; 2012 Dec; 23(6):428-30. PubMed ID: 21787214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Red light laser photodynamic therapy of Bowen's disease.
    Parlette EC
    J Drugs Dermatol; 2004; 3(6 Suppl):S22-4. PubMed ID: 15624738
    [No Abstract]   [Full Text] [Related]  

  • 16. Efficacy of photodynamic therapy with topical 5-aminolevulinic acid using intense pulsed light for Bowen's disease.
    Hasegawa T; Suga Y; Mizuno Y; Haruna K; Ogawa H; Ikeda S
    J Dermatol; 2010 Jul; 37(7):623-8. PubMed ID: 20629828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An open pilot study of ambulatory photodynamic therapy using a wearable low-irradiance organic light-emitting diode light source in the treatment of nonmelanoma skin cancer.
    Attili SK; Lesar A; McNeill A; Camacho-Lopez M; Moseley H; Ibbotson S; Samuel ID; Ferguson J
    Br J Dermatol; 2009 Jul; 161(1):170-3. PubMed ID: 19302071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorescence diagnosis and photodynamic therapy for Bowen's disease treatment.
    Truchuelo MT; Pérez B; Fernández-Guarino M; Moreno C; Jaén-Olasolo P
    J Eur Acad Dermatol Venereol; 2014 Jan; 28(1):86-93. PubMed ID: 23331846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methyl aminolaevulinate-photodynamic therapy for actinic keratoses, squamous cell carcinoma in situ and superficial basal cell carcinoma employing a square wave intense pulsed light device for photoactivation.
    Downs AM; Bower CB; Oliver DA; Stone CA
    Br J Dermatol; 2009 Jul; 161(1):189-90. PubMed ID: 19416229
    [No Abstract]   [Full Text] [Related]  

  • 20. Successful treatment for multiple Bowen's disease using photodynamic therapy: A case report.
    Wu MF; Lv T; Wang HW
    Photodiagnosis Photodyn Ther; 2020 Jun; 30():101783. PubMed ID: 32330610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.